HERTFORDSHIRE, England and
PITTSBURGH, Jan. 8, 2016 /PRNewswire/ -- Mylan N.V.
(NASDAQ, TASE: MYL) today announced that John Sheehan has advised the company of his
intention to retire from his position as CFO of Mylan, effective
April 1, 2016. Mylan's Board of
Directors has initiated a search to identify a replacement for Mr.
Sheehan.
Mylan Executive Chairman Robert J.
Coury commented, "John has served with distinction as
Mylan's CFO for the past six years, contributing significantly to
Mylan's success during this time and helping to ensure that we
delivered consistently strong financial performance. Importantly,
John has demonstrated all of the qualities that make Mylan so
special: dedication to our mission, passionate leadership and an
unwavering commitment to doing what is right. I am extremely
grateful to John for his service to Mylan and for helping to
position the company so well for the future."
Mylan's CEO Heather Bresch added,
"John has been a valued partner since he joined Mylan in 2010 and,
during the next several months, he will help to ensure a smooth
transition of his CFO responsibilities while we identify a
successor. We have in place the financial strength and flexibility,
strong business momentum and deep leadership team to ensure Mylan's
continued growth and success. We thank John for his many
contributions and wish him all the best in the future."
Mr. Sheehan said, "I am very grateful for the opportunity to
have served as CFO of Mylan during such an exciting period of
growth and expansion for the company. This has been the most
professionally rewarding experience of my career and I am very
proud of all that Mylan has accomplished. I am confident that the
talented and dedicated team here will continue to drive strong
growth and shareholder value going forward, and I look forward to
handing the reins over to my successor."
This press release includes statements that constitute
"forward-looking statements," including with regard to Mylan having
in place the financial strength and flexibility, strong
business momentum and deep leadership team to ensure Mylan's
continued growth and success and that its talented and dedicated
team will continue to drive strong growth and shareholder value
going forward. These statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Because such statements inherently involve risks and
uncertainties, actual future results may differ materially from
those expressed or implied by such forward-looking statements.
Factors that could cause or contribute to such differences include,
but are not limited to: changes in the economic and financial
conditions of the businesses of Mylan; actions and decisions
of healthcare and pharmaceutical regulators, and changes in
healthcare and pharmaceutical laws and regulations, in the United States and abroad; other
uncertainties and matters beyond the control of management; and the
other risks detailed in the company's filings with the Securities
and Exchange Commission. The company undertakes no obligation to
update these statements for revisions or changes after the date of
this release.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of more than 1,400 generic and branded pharmaceuticals,
including antiretroviral therapies on which nearly 50% of people
being treated for HIV/AIDS in the developing world depend. We
market our products in approximately 165 countries and territories.
Our global R&D and manufacturing platform includes more than 50
facilities, and we are one of the world's largest producers of
active pharmaceutical ingredients. Every member of our more than
30,000-strong workforce is dedicated to creating better health for
a better world, one person at a time. Learn more at mylan.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-cfo-john-sheehan-to-retire-as-of-april-1-2016-300201481.html
SOURCE Mylan N.V.